Characterization and regulation of AcrABR, a RND-type multidrug efflux system, in Agrobacterium tumefaciens C58. Nuonming P, Khemthong S, Dokpikul T, Sukchawalit R, Mongkolsuk S. Microbiol Res. 2018 Sep;214:146-155. doi: 10.1016/j.micres.2018.06.014. Epub 2018 Jul 10.

28 Dec 2018
0
0

Characterization and regulation of AcrABR, a RND-type multidrug efflux system, in Agrobacterium tumefaciens C58.
Nuonming P, Khemthong S, Dokpikul T, Sukchawalit R, Mongkolsuk S.
Microbiol Res. 2018 Sep;214:146-155. doi: 10.1016/j.micres.2018.06.014. Epub 2018 Jul 10.

Tags

Share this

Related Posts

NieR is the repressor of a NaOCl-inducible efflux system in Agrobacterium tumefaciens C58. Duang-Nkern J, Nontaleerak B, Udomkanarat T, Saninjuk K, Sukchawalit R, Mongkolsuk S. Microbiol Res. 2021 Oct;251:126816. doi: 10.1016/j.micres.2021.126816. Epub 2021 Jul 10. PMID: 34273784
01 Oct 2021
0

NieR is the repressor of a NaOCl-inducible efflux system in Agrobacterium tumefaciens C58. Duang-Nkern J, Nontaleerak B, Udomkanarat T, Saninjuk K, Sukchawalit R, Mongkolsuk S. Microbiol Res. 2021 Oct;251:126816. doi: 10.1016/j.micres.2021.126816. Epub 2021 Jul 10. PMID: 34273784

NieR is the repressor of a NaOCl-inducible efflux system in Agrobacterium tumefaciens C58. Duang-Nkern J, Nontaleerak B, Udomkanarat T, Saninjuk K, Sukchawalit R, Mongkolsuk S. Microbiol Res. 2021 Oct;251:126816. doi: 10.1016/j.micres.2021.126816. Epub 2021 Jul 10. PMID: 34273784
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More